Mar Buendia
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress.
Journal: Scientific reports
Published: December 12, 2022
Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose Finding.
Journal: The journal of prevention of Alzheimer's disease
Published: July 16, 2022
The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening.
Journal: Alzheimer's research & therapy
Published: January 15, 2021
Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain.
Journal: Journal of Alzheimer's disease : JAD
Published: September 28, 2020
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study.
Journal: Alzheimer's research & therapy
Published: July 11, 2019
Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.
Journal: Journal of Alzheimer's disease : JAD
Published: March 23, 2018
Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.
Journal: Journal of Alzheimer's disease : JAD
Published: November 21, 2017
Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.
Journal: Alzheimer's research & therapy
Published: September 04, 2017
Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
Journal: Journal of Alzheimer's disease : JAD
Published: March 09, 2017
Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.
Journal: Journal of Alzheimer's disease : JAD
Published: December 03, 2016
Association between cell-bound blood amyloid-β(1-40) levels and hippocampus volume.
Journal: Alzheimer's research & therapy
Published: January 14, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026